Hologic receives approval for ThinPrep Genesis
May 24, 2021—Hologic announced the FDA has granted premarket approval of the company’s ThinPrep Genesis processor for cytology processing and specimen transfer for downstream applications.
Webinars and Sponsored Roundtables — Register Now
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Bio-Rad launches InteliQ Diabetes Control
May 21, 2021–Bio-Rad Laboratories launched its InteliQ Diabetes Control, the 10th product offered in the InteliQ format.
Beckman launches fully quantitative COVID-19 IgG test
May 20, 2021—Beckman Coulter launched its Access SARS-CoV-2 IgG (1st IS), a fully quantitative lab-based immunoglobulin G serology test that measures the quantity of antibodies against the virus that causes COVID-19.
FDA greenlights Medbaye Clirra application
May 19, 2021—Medical software company Medbaye announced the availability of its Clirra application after it received clearance under the FDA’s guidelines for device software functions and mobile medical applications.
QIAreach Anti-SARS-CoV-2 Total Test receives EUA
May 17, 2021—Qiagen received emergency use authorization for its QIAreach Anti-SARS-CoV-2 Total Test, a digital assay to detect total SARS-CoV-2 antibodies (IgA, IgG, IgM).
FDA clears GSD’s B. burgdorferi VlsE-OspC IgG/IgM assay
May 14, 2021—Gold Standard Diagnostics announced the availability of its FDA-cleared B. burgdorferi VlsE-OspC IgG/IgM recombinant ELISA screen.
Beckman Coulter launches its DxA 5000 Fit for mid-size labs
May 4, 2021—Beckman Coulter launched its DxA 5000 Fit, a workflow automation solution for medium-size labs that run fewer than 5,000 tests a day.
Orchard Software acquires Corwen
May 3, 2021—Orchard Software has acquired Corwen, LLC, to expand molecular testing LIS support.
FDA approves Roche MMR test as a companion diagnostic
April 23, 2021—Roche announced FDA approval of the Ventana MMR RxDx Panel for advanced or recurrent endometrial cancer patients.
Bio-Rad launches SARS-CoV-2 variant RT-PCR assays
April 21, 2021—Bio-Rad Laboratories launched SARS-CoV-2 Variant RT-PCR Assays for research use only.